AGOSTINO, RITA MARIA
 Distribuzione geografica
Continente #
NA - Nord America 332
EU - Europa 242
AS - Asia 122
Totale 696
Nazione #
US - Stati Uniti d'America 329
IE - Irlanda 89
SE - Svezia 70
CN - Cina 69
IT - Italia 31
SG - Singapore 31
DE - Germania 17
HK - Hong Kong 13
FI - Finlandia 10
BE - Belgio 8
FR - Francia 8
IN - India 7
CA - Canada 3
CZ - Repubblica Ceca 2
ES - Italia 2
NL - Olanda 2
AL - Albania 1
GB - Regno Unito 1
ID - Indonesia 1
JP - Giappone 1
UA - Ucraina 1
Totale 696
Città #
Chandler 97
Dublin 89
Nyköping 45
Singapore 25
Ann Arbor 22
Beijing 22
New York 22
Ashburn 20
Dearborn 15
Princeton 14
Messina 13
Jacksonville 12
Medford 11
Boardman 10
Bremen 8
Brussels 8
Des Moines 8
Cambridge 7
Munich 7
Nanjing 7
Helsinki 6
Seattle 6
Pune 5
Shenyang 5
Zhengzhou 5
Hangzhou 4
Los Angeles 4
Sheung Shui 4
Central 3
Houston 3
Jinan 3
San Mateo 3
Amsterdam 2
Changsha 2
Córdoba 2
Fiumefreddo Di Sicilia 2
Fuzhou 2
Guangzhou 2
Hebei 2
Hyderabad 2
Milan 2
Nanchang 2
Riva 2
Wilmington 2
Baoding 1
Brno 1
Changle 1
Clearwater 1
Haikou 1
Jakarta 1
Kunming 1
Limeil-brévannes 1
Matawan 1
Milazzo 1
Ningbo 1
Olomouc 1
Pisa 1
San Francisco 1
Santa Clara 1
Strasbourg 1
Taiyuan 1
Taizhou 1
Tappahannock 1
Tianjin 1
Toronto 1
Totale 558
Nome #
Effects of strontium ranelate on bone mass and bone turnover in women with thalassemia major-related osteoporosis 89
Activity of pegylated liposomal doxorubicin in combination with gemcitabine in triple negative breast cancer with skin involvement: Two case reports. 82
Quality of life and psychological functioning in postmenopausal women undergoing aromatase inhibitor treatment for early breast cancer 71
TRABECULAR BONE SCORE IS PREDICTED BY PHALANGEAL QUANTITATIVE ULTRASOUND IN BREAST CANCER POSTMENOPAUSAL WOMEN RECEIVING AROMATASE INHIBITORS 67
Phalangeal quantitative ultrasound to investigate bone changes in aromatase inhibitor-treated breast cancer women receiving denosumab 63
EFFECTS OF DENOSUMAB ON QUANTITATIVE ULTRASOUND AND DUAL-ENERGY X-RAY ABSORPTIOMETRY MEASUREMENTS IN AROMATASE INHIBITOR-TREATED BREAST CANCER WOMEN 63
AB0823 TRABECULAR BONE SCORE AT LUMBAR SPINE IS ASSOCIATED WITH QUANTITATIVE ULTRASOUND MEASUREMENTS AT PHALANGEAL SITE IN BREAST CANCER SURVIVORS RECEIVING AROMATASE INHIBITORS 63
Strontium ranelate improves bone mineral density in thalassemia major related osteoporosis and reduces sclerostin levels 62
Phalangeal quantitative ultrasound detects changes of bone status in aromatase inhibitor-treated breast cancer women. 61
Trabecular bone score and quantitative ultrasound measurements in the assessment of bone health in breast cancer survivors assuming aromatase inhibitors 49
Phalangeal quantitative ultrasound as assessment tool to evaluate bone loss in aromatase inhibitors related osteoporosis 46
Renal Function Is Associated with Changes in Bone Mineral Density in Postmenopausal Osteoporotic Women Treated with Denosumab: Data From a Retrospective Cohort Study 4
Totale 720
Categoria #
all - tutte 2.997
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.997


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202059 0 0 0 0 0 15 12 5 5 19 3 0
2020/202160 6 1 25 4 9 1 1 1 0 9 2 1
2021/202297 1 9 4 4 2 0 10 3 6 15 9 34
2022/2023288 22 38 12 27 19 33 1 19 106 1 7 3
2023/202498 5 10 3 9 3 30 3 21 0 1 1 12
2024/202567 10 14 3 16 15 9 0 0 0 0 0 0
Totale 720